Suppr超能文献

相似文献

1
Graves' ophthalmopathy.
N Engl J Med. 2010 Feb 25;362(8):726-38. doi: 10.1056/NEJMra0905750.
2
Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
J Clin Endocrinol Metab. 2009 Oct;94(10):3700-7. doi: 10.1210/jc.2009-0747. Epub 2009 Sep 1.
4
Management of Graves' hyperthyroidism: present and future.
Expert Rev Endocrinol Metab. 2022 Mar;17(2):153-166. doi: 10.1080/17446651.2022.2052044. Epub 2022 Mar 14.
5
Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.
Neuroimmunomodulation. 2011;18(1):45-51. doi: 10.1159/000311519. Epub 2010 Jul 13.
7
Effects of block-replace regimen in patients with autoimmune hypothyroidism converted to Graves' disease.
Hormones (Athens). 2024 Mar;23(1):107-111. doi: 10.1007/s42000-023-00496-w. Epub 2023 Oct 13.
8
Radioiodine therapy versus antithyroid medications for Graves' disease.
Cochrane Database Syst Rev. 2016 Feb 18;2(2):CD010094. doi: 10.1002/14651858.CD010094.pub2.
10
The tale of radioiodine and Graves' orbitopathy.
Thyroid. 2010 Jul;20(7):785-93. doi: 10.1089/thy.2010.1640.

引用本文的文献

1
Oxidative stress-related biomarkers in thyroid eye disease: evidence from bioinformatics analysis and experimental validation.
Front Immunol. 2025 Aug 18;16:1635712. doi: 10.3389/fimmu.2025.1635712. eCollection 2025.
2
Bibliometrics in thyroid eye disease.
J Endocrinol Invest. 2025 Aug 29. doi: 10.1007/s40618-025-02688-0.
3
CAR T-cell therapy in autoimmune diseases: a promising frontier on the horizon.
Front Immunol. 2025 Aug 12;16:1613878. doi: 10.3389/fimmu.2025.1613878. eCollection 2025.
6
Extending the Graves' Triad: Thyroid Eye Disease, Dermopathy, and Acropachy: A Clinical Response to Teprotumumab.
JCEM Case Rep. 2025 Aug 13;3(9):luaf156. doi: 10.1210/jcemcr/luaf156. eCollection 2025 Sep.
7
Glymphatic System Dysfunction in Thyroid Eye Disease Associated with Disease Activity and Duration.
J Inflamm Res. 2025 Aug 4;18:10489-10498. doi: 10.2147/JIR.S532401. eCollection 2025.
10
An Atypical Presentation of Thyroid Eye Disease in a Patient With a Remote History of Graves' Disease.
Cureus. 2025 Jun 23;17(6):e86621. doi: 10.7759/cureus.86621. eCollection 2025 Jun.

本文引用的文献

2
TGF-beta and fibrosis in different organs - molecular pathway imprints.
Biochim Biophys Acta. 2009 Aug;1792(8):746-56. doi: 10.1016/j.bbadis.2009.06.004. Epub 2009 Jun 17.
3
Anakinra for rheumatoid arthritis: a systematic review.
J Rheumatol. 2009 Jun;36(6):1118-25. doi: 10.3899/jrheum.090074. Epub 2009 May 15.
5
Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.
Br J Ophthalmol. 2009 Aug;93(8):1052-6. doi: 10.1136/bjo.2007.137265. Epub 2009 Feb 15.
6
Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates.
Clin Immunol. 2009 May;131(2):360-5. doi: 10.1016/j.clim.2008.12.005. Epub 2009 Feb 4.
7
Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk.
AJNR Am J Neuroradiol. 2009 Mar;30(3):597-602. doi: 10.3174/ajnr.A1413. Epub 2009 Jan 15.
9
Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies.
Clin Immunol. 2009 Mar;130(3):252-8. doi: 10.1016/j.clim.2008.09.007. Epub 2008 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验